Carol A Sartorius

10PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical physicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 28, 2026
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases.

|Apr 04, 2026
Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer.

Virginia Figueroa, Marcela I Coianis, Ana Sahores

|Nov 08, 2025
Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAs.

Jessica Finlay-Schultz, Kiran Vinod Paul, Benjamin Erickson

|Jun 19, 2024
Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells.

Ashley V Ward, Duncan Riley, Kirsten E Cosper

|Aug 24, 2022
Transcription factor-nucleosome dynamics from plasma cfDNA identifies ER-driven states in breast cancer.

Satyanarayan Rao, Amy L Han, Alexis Zukowski

|May 31, 2022
Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer.

Olivia McGinn, Duncan Riley, Jessica Finlay-Schultz

Pageof 2

Frequent Collaborators

3 joint publications

Jessica Finlay-Schultz

2 joint publications

Peter Kabos

2 joint publications

Peter Kabos

1 joint publications

Ashley V Ward